Companies › TPST

Tempest Therapeutics Inc (TPST)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001544227 · EDGAR filings · Updated 2026-07-28

Tempest Therapeutics Inc (TPST) has reported institutional ownership of 3.6%, with 21 institutional managers holding positions valued at $848.1K per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.

Filings this week (3)

• 2026-07-28 — DEFA14A filed
• 2026-07-28 — Current report (8-K) filed
• 2026-07-22 — Current report (8-K) filed

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

• 2026-07-17 — Proxy statement (DEF 14A) filed
• 2026-07-08 — Prospectus supplement (424B3) filed
• 2026-07-07 — EFFECT filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, Tempest Therapeutics Inc has 21 institutional holders and institutional ownership of 3.6%.

Insider activity

Insiders reported 1 transactions (1 buys, 0 sells) across 1 reporting insiders, with a net reported value of $500.0K.

Data flags from SEC filings

Related companies

BIOAFFINITY TECHNOLOGIES INC (BIAF) · Citius Pharmaceuticals Inc (CTXR) · BULLFROG AI HLDGS INC (BFRG) · BioCardia Inc (BCDA) · INTENSITY THERAPEUTICS INC (INTS) · Phio Pharmaceuticals Corp (PHIO)